Phase I study of intravenously administered ATI-1123, a liposomal docetaxel formulation in patients with advanced solid tumors
Titel:
Phase I study of intravenously administered ATI-1123, a liposomal docetaxel formulation in patients with advanced solid tumors
Auteur:
Mahalingam, Devalingam Nemunaitis, John J. Malik, Laeeq Sarantopoulos, John Weitman, Steven Sankhala, Kamalesh Hart, Jessica Kousba, Ahmed Gallegos, Nicole S. Anderson, Gavin Charles, John Rogers, Jon M. Senzer, Neil N. Mita, Alain C.